Increasing multidrug-resistance to Gram-positive pathogens, particularly to staphylococci,
enterococci and streptococci, is a major problem, resulting in significant morbidity, mortality …

Antimicrobial resistance (AMR) remains one of the top public health issues of global
concern. Among the most important strategies for AMR control there is the correct and …

A number of novel antimicrobial drugs with activity against Gram-positive bacterial
pathogens have been licensed in the past 4 years. These drugs have the potential to enrich …

Multidrug resistance in Gram-positive pathogens emerged as a major therapeutic challenge
over two decades ago. The worldwide spread of methicillin-resistant Staphylococcus aureus …

Introduction: Staphylococcus aureus and Enterococcus spp. are two of the most common
organisms causing nosocomial infections today; and are consistently associated with high …

Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a
global level during the last decades and represent an everyday challenge, especially for the …

Background The number of antibiotics in the pipeline targeting Gram-positive pathogens has
increased in recent years. Aims This narrative review aims to provide a summary of existing …

Antibiotic resistance is a major public health concern, with fears expressed that we shortly
will run out of antibiotics. In reality, the picture is more mixed, improving against some …

Antimicrobial resistance is a growing threat to public health and an increasingly common
problem for acute care physicians to confront. Several novel antibiotics have been approved …

With the continuing development of clinical drug resistance among bacteria and the advent
of resistance to the recently released agents quinupristin-dalfopristin and linezolid, the need …